← Back to Search

Regenerative Medicine

Umbilical Cord Allograft for Musculoskeletal Pain/Injuries

N/A

Waitlist Available

Research Sponsored by R3 Stem Cell

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 and over.

Competent to understand the study protocol and provide voluntary informed consent

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and then assess changes post intervention at 4 weeks, 3 mths, 6 mths, 9 mths and one year

Awards & highlights

Study Summary

This trial is testing whether a product made from amniotic fluid can help relieve pain and improve function for people with all types of musculoskeletal conditions.

Who is the study for?

This trial is for adults over 18 with various musculoskeletal conditions like pelvic pain, sports injuries, arthritis, and more. Participants must understand the study and consent to it, as well as commit to follow-up visits or remote check-ins. Pregnant or breastfeeding individuals, those with active infections or clotting disorders cannot join.Check my eligibility

What is being tested?

The trial is testing an Amniotic Fluid Tissue Product (Umbilical Allograft) for relieving pain and improving function in musculoskeletal conditions. It's a forward-looking study that will measure outcomes at different times after the treatment.See study design

What are the potential side effects?

While specific side effects are not listed here, similar treatments may cause injection site reactions, infection risk increase, allergic responses or no improvement in symptoms.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I understand the study details and agree to participate voluntarily.

Select...

I am 18 years old or older.

Select...

I understand the study details and agree to participate.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and then assess changes post intervention at 4 weeks, 3 mths, 6 mths, 9 mths and one year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and then assess changes post intervention at 4 weeks, 3 mths, 6 mths, 9 mths and one year

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and then assess changes post intervention at 4 weeks, 3 mths, 6 mths, 9 mths and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Short Musculoskeletal Function Assessment Questionnaire (SMFA)

Secondary outcome measures

Visual Analog Scale (VAS)

Work Status

Trial Design

1Treatment groups

Experimental Treatment

Group I: Umbilical AllograftExperimental Treatment1 Intervention

The study is nonrandomized with one arm. Depending on the body area being treated, the amount of the product utilized will be either 1.0cc's or 2cc's.

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

R3 Stem CellLead Sponsor

2 Previous Clinical Trials

5,100 Total Patients Enrolled

Media Library

Osteoarthritis Research Study Groups: Umbilical Allograft

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can patients sign up for this research project at this time?

"According to the latest update on clinicaltrials.gov, this particular study is not looking for new patients at the moment. This research was first made public on January 1st, 2022 but has not been updated since September 10th, 2021. Although this trial isn't currently recruiting, there are 1935 other trials that are still enrolling candidates."

Answered by AI

Who else is applying?

What state do they live in?

Nevada

Ohio

Other

California

What portion of applicants met pre-screening criteria?

Met criteria

What site did they apply to?

Stem Cell Therapy of Las Vegas

Advanced Stem Cell Institute

How many prior treatments have patients received?

Why did patients apply to this trial?

I've never tried any medication and hope this will help. I am interested in alternatives to fusion and I want to contribute to research.

PatientReceived 2+ prior treatments

Would love relief from pain and discomfort, and interested in helping others find relief.

PatientReceived no prior treatments

I have pain in my knees. My left knee has a radial tear of the meniscus. I have only been offered menisectomy as a treatment choice and this will only lead to increased osteoarthritis and eventually total knee replacement. I am interested to be part of this study to see if stem cells will help.

PatientReceived 2+ prior treatments

I am frustrated that my life has diminished because of OA, back issues with stenosis and discs and there are no good treatment options available. I've been interested in stem cell therapy for a while but have not made a decision if I think my own stem cells should be the source. Umbilical derived cells seem like a better option. I think this approach has great promise and it is time that we have more research into umbilical derived options in the US.

PatientReceived 2+ prior treatments